|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: NORTHWEST PIPE CO, 10-Q, EX-10.25, 2000-11-13 |
Next: GELTEX PHARMACEUTICALS INC, 425, 2000-11-13 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED FINANCIAL STATEMENTS FOUND IN THE COMPANY'S FORM 10-Q FOR
THE NINE MONTH PERIOD ENDED SEPTEMBER 30, 2000 AND IS QUALIFIED IN ITS
ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 4,371
<SECURITIES> 0
<RECEIVABLES> 58,408
<ALLOWANCES> 550
<INVENTORY> 45,432
<CURRENT-ASSETS> 175,106
<PP&E> 123,560
<DEPRECIATION> 34,223
<TOTAL-ASSETS> 289,316
<CURRENT-LIABILITIES> 98,979
<BONDS> 0
0
0
<COMMON> 65
<OTHER-SE> 105,276
<TOTAL-LIABILITY-AND-EQUITY> 289,316
<SALES> 209,467
<TOTAL-REVENUES> 209,467
<CGS> 172,676
<TOTAL-COSTS> 172,676
<OTHER-EXPENSES> 15,828
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 7,518
<INCOME-PRETAX> 13,445
<INCOME-TAX> 5,378
<INCOME-CONTINUING> 8,067
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 8,067
<EPS-BASIC> 1.25
<EPS-DILUTED> 1.22
</TABLE>
|
|